Poor health, which can be caused by sleep disorders including sleep apnea, insomnia, restless leg syndrome, is a common problem. What’s more, when treatment isn’t covered or only covered in part—as when purchasing...
A nationwide multi-center trial is enrolling patients to evaluate an investigational drug called nelotanserin as a potential treatment for RBD in people with dementia with Lewy Bodies and Parkinson’s disease dementia.
Invacare names Joseph S. Lewarski as vice president, respiratory products group.
Poor health, which can be caused by sleep disorders including sleep apnea, insomnia, restless leg syndrome, is a common problem. What’s more, when treatment isn’t covered or only covered in part—as when purchasing...